FDA DEVICE FACTS
HealthCCSng
Nano-X AI Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The HealthCCSng device is intended for use as non-invasive post-processing software to evaluate calcified plaques in the coronary arteries, which present a risk for coronary artery disease. The HealthCCSng device analyzes routine non-gated, non-contrast CT studies that include the entire heart of adult patients aged 30-85. The device generates an exact calcium score and a four-category coronary artery calcium detection output representing the estimated quantity of calcium detected, together with preview axial images of the detected calcium meant for informational purposes only. The device output will be available to the radiologist as part of their standard workflow. A list of studies that received a successful algorithm analysis result will also be available for further clinician assessment, such as by a cardiologist or general practitioner. The HealthCCSng results are not intended to be used on a standalone basis for risk attribution or clinical decision-making, or otherwise preclude clinical assessment of CT studies.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。